Le Lézard
Classified in: Health
Subject: SVY

Global e-Clinical Trial Technologies Business Report 2018 - Increasing Investments in Clinical Research Drive the Global e-Clinical solutions Market


DUBLIN, Feb. 23, 2018 /PRNewswire/ --

The "e-Clinical Trial Technologies - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. This report analyzes the worldwide markets for e-Clinical Trial Technologies in US$ Million. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The Global market for e-Clinical Trial Technologies in this report is analyzed by the following Segments:

The Global Electronic Data Capture (EDC) Market in this report is analyzed by the following Clinical Trial Phase:

The Global Clinical Trial Management System (CTMS) Market in this report is analyzed by the following Product Type:

The report profiles 84 companies including many key and niche players such as:

Key Topics Covered:

1. INDUSTRY OVERVIEW
A Prelude
Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial Technologies
Global Market Overview
Increasing Investments in Clinical Research Drive the Global e-Clinical solutions Market
Clinical Trials Adopt Technologies for Various Phases
e-Clinical Trial Technologies Market by Delivery Mode
Major Players
Market Gravitates from Developed Countries to Developing Countries
Outsourcing of Clinical Studies to Developing Countries Benefits Market
Globalization Boosts e-Clinical Trials Market
Key Challenges for e-Clinical Trials
Role of Contract Research Organizations (CROs) in Clinical Activity
Major CROs with Internally Developed CTMS Systems
CRO Acquisitions: Clinical Trial Technologies

2. SEGMENT ANALYSIS
Electronic Data Capture (EDC)
EDC Segment Witnesses Rapid Growth
EDC Platforms Utilized by Select CROs
Competition
Medidata Solutions Inc.
A Leading EDC Provider
Select Customers of Medidata's Rave
Select Customers of Oracle's EDC
Factors influencing EDC Selection
Vendors Track Record
Regulatory Compliance
Data Security Standards
Trend towards Third-Party EDC Systems Gains Momentum
EDCs Boost Use of Clinical Trials
EDC for Monitoring Patient Logistics
EDC and Direct Monitoring of Patients
EDC for Managing Medical Records
Clinical Trial Management Systems (CTMS) Market
Tangible Cost-Savings Bolster Rapid Uptake of CTMS Solutions
Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
Increased Demand for Cloud-based and Other Advanced CTMS
Key Players in the CTMS Market
Select Major Clinical Trial Management Systems (CTMS) Providers Worldwide
Impact of CTMS and other Services on Pharma Industry
Electronic Patient Record Outcome (ePRO)
Electronic Patient Record (ePRO) Solutions Replace Paper- Based PRO systems
Select ePRO Vendors
Major Technology Trends Expected to Revolutionize the ePro Market
Big Data
Wearable Health Trackers Becoming Mainstream
BYOD Strategy
Growing Usage of Tablets and Mobile
Real-time Feedback and Insights
Adopting Cloud and Multi-tenant SaaS
Consumerization of User Experience
ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies
Randomization and Trial Supply Management (RTSM)
Preference Grows for Customized/Configured RTSM
Interactive Voice Response System (IVRS)
Multifarious Operational Benefits Drive IVRS Adoption
Globalization of Clinical Trials Throws Up Challenges for IVR/IWR System Developers

3. KEY GROWTH DRIVERS AND MARKET TRENDS
Surging Global Population Offers Increased Growth Opportunities
Pharmaceutical Firms and CROs to Drive Adoption Rate
Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies Demand
CROs
The Targeted Customers for e-Clinical Trial Technologies
Outsourcing of R&D Projects to Propel CRO Market, Driving Demand
Noteworthy Contracts of Major CROs
CROs Adept with New Technologies to See More Business in Future
Increased Importance of e-Clinical Integration
Big Data and Patient Centricity: Areas to Increase Focus Upon
Esource Documentation Witnesses Increased Traction
Increased Adoption of electronic Trial Master File (eTMFs)
Risk-Based Monitoring Witnesses New Modifications
Growing Implementation of e-Consent
Increased Investments in Virtual Clinical Trials
Open Source
Emerging Solutions in Clinical Trials Domain
Select Open Source Technologies for Clinical Trials by Application Area
Benefits over Proprietary Technologies to Encourage Adoption
EDC- The Most Attractive Application for Open Source
Conversion to CDISC
An Emerging Application for Open Source Solutions
Mobile Technologies to Help Trial Operators in Tackling Challenges
Smartphones & Tablets: The New Age ePRO Devices

4. PRODUCT PROFILE
Defining e-Clinical Trials
e-Clinical Solutions Enhance Clinical Trial Efficiency
Key Advantages offered by Integrated e-Clinical Solutions include:
Effective Deployment of an e-Clinical Solution
Enterprise-Level Benefits
Benefits Offered by e-Clinical Trials
Transparency
Dynamic Program Management
Effective Trial Drug Supply
Effective Study Randomization
Enhanced Collaboration
Dynamic Site Management
Less Frequent Investigational Site Visits
Faster Go No-Go Decisions
Better Planning
Regulatory Compliance
CDISC Standards
Clinical Trials
In a Nutshell
Summarization of Clinical Trial Phases & Time Line for Drug Development
Systems Used in e-Clinical Trials
Electronic Data Capture Solutions (EDC)
Benefits of EDC
EDC and Paper CRFs
A Comparison
Recent Advancements in EDC
Clinical Trial Management System (CTMS)
CDMS to CTMS: The Evolutionary Move to eDevelopment
CROs
The Targeted Customers for CTMS
Clinical Trial Image Management System (CTMS)
Electronic Patient Reported Outcome (ePRO)
Electronic Diaries
Randomization and Trial Supply Management (RTSM)
Interactive Voice Response Systems (IVRS)
Technologies Used in IVR
Interactive Web Response Systems (IWRS)

5. PRODUCT/SERVICE INTRODUCTIONS
ArisGlobal Introduces LifeSphere Clinical
Oracle Health Sciences Unveils Oracle Clinical One
MedNet Solutions Introduces iMedNet
Prelude Dynamics Introduces Two Solutions
PAREXEL Unveils Patient Sensor Solution
Prelude Dynamics Introduces VISION 9
Veeva Systems Unveils Veeva Vault EDC and eSource
Bioclinica Introduces Safety and Regulatory Software Products
DZS Clinical Services Unveils ClinPlus 3.1e-Clinical Software
Bioclinica Introduces OnPoint Direct
Bioclinica Demonstrates EDC System from EHR to CDASH CRFs
BioClinica Introduces e-Clinical CRO Partner Alliance Program
DATATRAK Introduces UX CTMS 360

6. RECENT INDUSTRY ACTIVITY
Novum Selects OmniComm's TrialMaster EDC
OmniComm Inks Contract with Beijing Hospital of the Ministry of Health
Montrium Partners with MAPS
MedNet Solutions Partners with arivis
OmniComm Systems Secures EU-U.S. Privacy Shield Certification
SRD Selects OmniComm's TrialMaster EDC Technology
AB Cube Joins Health App xChange
Anju Software Acquires ClinPlus
DATATRAK Partners with Sisense
Orbita Collaborates with ERT
MedNet Solutions Obtains Privacy Shield Certification
Medidata Acquires Mytrus
Medidata Partners with Karyopharm
OmniComm Collaborates with Bio-Optronics
OmniComm Systems Signs Agreement with MediStat
OmniComm Signs Landmark Contracts with Major Clinical Research Organizations
Almac Group Collaborates with Exostar
ERT Takes Over Exco InTouch
Almac Group Partners with inVentiv Health
OmniComm Provides EDC Services to a Major Research Hospital
Bracket Acquires CLINapps
e-ClinicalHealth Collaborates with Clinerion
Orbus Therapeutics Selects DSG to Provide Fully Supported eCaseLink EDC System
Cinven Acquires Bioclinica
Top 15 Pharma Company Selects TrialOne to Automate its Entire Phase I/BA & BE Clinic
Parallel 6 Joins Bioclinic's eHealth App xChange
Pfizer Selects Oracle's Clinical Trial Technologies
IMS Health Merges with Quintiles
OmniComm System Inks five-year, Multi-Million Dollar Agreement with CROMSOURCE
OmniComm Inks Agreement with Canadian Pharmaceutical Drug Developer
Bioclinica Provides RBM Solution for Clinical Trials
Bioclinica Takes Over Clinverse
Parallel 6 Acquires nPruv
Clinlogix Partners with MedNet Solutions
OmniComm Inks five year, Multi-Million Dollar Agreement with Major CRO
Global Biopharmaceutical Selects TrialMaster EDC for CNS Drug Trials
Integrium Inks Licensing Agreement for DSG's eCaseLink Solutions & Services
BioClinica Partners with Kinapse
ERT Acquires Boston-based PHT Corporation
Clinical Ink Mergers with CentrosHealth
PRA Health Sciences Acquires Value Health Solutions
OmniComm Systems Buys IRT Technology From Clinquest

7. FOCUS ON SELECT PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 84 (including Divisions/Subsidiaries 87)

For more information about this report visit https://www.researchandmarkets.com/research/cwdnmn/global_eclinical?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



SOURCE Research and Markets


These press releases may also interest you

at 06:08
Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor® Reports First Quarter 2024 Results
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

More news about Health...


News published on and distributed by: